What REGENXBIO Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 2 | 2 |
| Sells | 0 | 5 |
| Total trades | 7 | 39 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 118,035 | 896,644 |
| Disposed | 17,303 | 382,605 |
| Net activity | +100,732 | +514,039 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Chan Mitchell | Chief Financial Officer | Sep 01 | Withheld — tax / exercise cost · F | −4,902 | $9.32 | −$45.7K | 122,815 |
| Malzahn Craig | Chief Technology Officer | Sep 01 | Withheld — tax / exercise cost · F | −234 | $9.32 | −$2.18K | 81,960 |
| Ciongoli Gregory Austin | Director | Aug 27 | Open-market buy · P | +53,407 | $9.36 | +$500K | 118,035 |
| Ciongoli Gregory Austin | Director | Aug 26 | Open-market buy · P | +49,196 | $9.14 | +$450K | 64,628 |
| Ciongoli Gregory Austin | Director | Aug 25 | Grant / award · A | +15,432 | — | — | 15,432 |
| Christmas Patrick J. | Chief Strategy & Legal Officer | Aug 01 | Withheld — tax / exercise cost · F | −4,699 | $9.69 | −$45.5K | 205,968 |
| Pakola Steve | Chief Medical Officer | Aug 01 | Withheld — tax / exercise cost · F | −7,468 | $9.69 | −$72.4K | 205,541 |
| Pakola Steve | Chief Medical Officer | Jul 02 | Open-market sale · S | −2,161 | $13.64 | −$29.5K | 213,009 |
| Pakola Steve | Chief Medical Officer | Jul 02 | Exercise / conversion · M | +2,161 | $7.86 | +$17K | 215,170 |
| Pakola Steve | Chief Medical Officer | Jul 01 | Open-market sale · S | −36,725 | $12.86 | −$472K | 213,009 |
| Pakola Steve | Chief Medical Officer | Jul 01 | Exercise / conversion · M | +36,725 | $7.86 | +$289K | 249,734 |
| Simpson Curran | Chief Executive Officer | Jul 01 | Withheld — tax / exercise cost · F | −6,818 | $13.09 | −$89.2K | 338,053 |
| Simpson Curran | Chief Executive Officer | Jun 30 | Grant / award · A | +1,453 | $10.18 | +$14.8K | 344,871 |
| Pakola Steve | Chief Medical Officer | Jun 29 | Open-market sale · S | −19,608 | $11.04 | −$216K | 213,009 |
| Fox Allan M. | Director | May 29 | Grant / award · A | +9,807 | — | — | 28,861 |
| Migausky George V | Director | May 29 | Grant / award · A | +9,807 | — | — | 28,861 |
| Bennett Jean | Director | May 29 | Grant / award · A | +9,807 | — | — | 28,861 |
| Karabelas Argeris N | Director | May 29 | Grant / award · A | +9,807 | — | — | 28,861 |
| Glucksmann Alexandra | Director | May 29 | Grant / award · A | +9,807 | — | — | 28,861 |
| Tasse Daniel | Director | May 29 | Grant / award · A | +9,807 | — | — | 28,861 |
Loading...
